Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
opioid medication
|
| gptkbp:activeDuring |
oxycodone
|
| gptkbp:administrativeDivision |
every 4 to 6 hours as needed
|
| gptkbp:availableFormats |
oral solution
extended-release tablet |
| gptkbp:brand |
gptkb:Roxicodone
|
| gptkbp:chemicalFormula |
C18H21NO4
|
| gptkbp:contraindication |
severe asthma
intestinal obstruction hypersensitivity to oxycodone |
| gptkbp:diseaseResistance |
possible
|
| gptkbp:dosageForm |
5 mg
15 mg 30 mg immediate-release tablet |
| gptkbp:drugInterdiction |
high
|
| gptkbp:formFactor |
tablet
|
| gptkbp:gestationPeriod |
Category B
|
| https://www.w3.org/2000/01/rdf-schema#label |
Roxicodone
|
| gptkbp:interactsWith |
gptkb:MAO_inhibitors
alcohol CNS depressants |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mandates |
moderate to severe pain
|
| gptkbp:manufacturer |
gptkb:Purdue_Pharma
|
| gptkbp:marketedAs |
gptkb:Roxicodone
Oxycodone HCl |
| gptkbp:notableFeature |
gptkb:OxyContin
Percocet |
| gptkbp:numberOfStudents |
3 to 4.5 hours
|
| gptkbp:nutritionalValue |
liver
|
| gptkbp:providesSupportFor |
II
|
| gptkbp:route |
oral
|
| gptkbp:sideEffect |
nausea
vomiting drowsiness constipation dry mouth |
| gptkbp:symptoms |
anxiety
nausea insomnia sweating respiratory depression muscle aches unconsciousness bradycardia cold and clammy skin pinpoint pupils |
| gptkbp:usedFor |
pain relief
|